FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3024363162> ?p ?o ?g. }

• W3024363162 endingPage "4675" @default.
• W3024363162 startingPage "4667" @default.
• W3024363162 abstract "Abstract Background Several studies have suggested that antiplatelet (AP) or anticoagulant (AC) therapy may improve outcome in men with prostate cancer. We evaluated the effects of AP/AC therapy and tested the hypothesis that platelet count may also be associated with outcomes. Methods A total of 482 patients received primary radiotherapy (median dose 72 Gy) for nonmetastatic prostate cancer; 49% received androgen deprivation therapy. NCCN risk was low/intermediate/high risk in 39%/39%/22%. AP/AC therapy and platelet counts were analyzed with respect to freedom from biochemical failure (FFBF, nadir+2), distant metastasis (FFDM), and cause specific survival (CSS). Results After a median follow‐up of 103 months, 10‐year FFBF, FFDM, and CSS were 77%, 92%, and 96%, respectively. The 10‐year cumulative incidence of BF and DM (with death as a competing event) was 19% and 7.0%, respectively. The 32% of men on AP/AC therapy had a lower incidence of 10‐year BF ( P = .016) and a trend toward a lower incidence of DM ( P = .084) and CSS ( P = .091). In the entire cohort, lowest platelet quartile (platelet count <187) was associated with higher 10‐year BF (31% vs 16%, P = .0042) but not DM (9.4% vs 5.2%, P = .22) nor CSS ( P = .76) compared with those patients with platelet count ≥187. AP/AC therapy was associated with a larger absolute reduction in BF for men with lowest platelet quartile (10‐year BF of 21% vs 38%, P = .092) vs platelet ≥187 (10‐year BF of 10% vs 18%, P = .053). Lowest platelet quartile remained associated with higher BF and DM on multivariable analysis controlling for risk category, WBC, and Hg. Conclusion AP/AC was associated with improved FFBF. Low platelet count was associated with inferior FFBF and FFDM after prostate radiotherapy. This association was tempered when antiplatelet and anticoagulant therapy was administered." @default.
• W3024363162 created "2020-05-21" @default.
• W3024363162 creator A5009025020 @default.
• W3024363162 creator A5013587173 @default.
• W3024363162 creator A5045072724 @default.
• W3024363162 creator A5046168760 @default.
• W3024363162 date "2020-05-13" @default.
• W3024363162 modified "2023-09-27" @default.
• W3024363162 title "Improved outcomes after radiotherapy for prostate cancer: Anticoagulation, antiplatelet therapy, and platelet count as key factors in disease progression" @default.
• W3024363162 cites W1964973202 @default.
• W3024363162 cites W1968519475 @default.
• W3024363162 cites W1970644541 @default.
• W3024363162 cites W1976526796 @default.
• W3024363162 cites W1983600360 @default.
• W3024363162 cites W1986726610 @default.
• W3024363162 cites W1994351520 @default.
• W3024363162 cites W2035362880 @default.
• W3024363162 cites W2035548675 @default.
• W3024363162 cites W2040775233 @default.
• W3024363162 cites W2054324054 @default.
• W3024363162 cites W2058727554 @default.
• W3024363162 cites W2093867637 @default.
• W3024363162 cites W2125061065 @default.
• W3024363162 cites W2128271389 @default.
• W3024363162 cites W2138368121 @default.
• W3024363162 cites W2154966750 @default.
• W3024363162 cites W2157201048 @default.
• W3024363162 cites W2160972992 @default.
• W3024363162 cites W2395612161 @default.
• W3024363162 cites W2590280648 @default.
• W3024363162 cites W2735261543 @default.
• W3024363162 cites W2736105467 @default.
• W3024363162 cites W2737599392 @default.
• W3024363162 cites W2779115877 @default.
• W3024363162 cites W2804074242 @default.
• W3024363162 cites W2894812283 @default.
• W3024363162 cites W2972622809 @default.
• W3024363162 cites W2989181843 @default.
• W3024363162 cites W5694759 @default.
• W3024363162 doi "https://doi.org/10.1002/cam4.3087" @default.
• W3024363162 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7333841" @default.
• W3024363162 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32400122" @default.
• W3024363162 hasPublicationYear "2020" @default.
• W3024363162 type Work @default.
• W3024363162 sameAs 3024363162 @default.
• W3024363162 citedByCount "4" @default.
• W3024363162 countsByYear W30243631622020 @default.
• W3024363162 countsByYear W30243631622021 @default.
• W3024363162 countsByYear W30243631622022 @default.
• W3024363162 countsByYear W30243631622023 @default.
• W3024363162 crossrefType "journal-article" @default.
• W3024363162 hasAuthorship W3024363162A5009025020 @default.
• W3024363162 hasAuthorship W3024363162A5013587173 @default.
• W3024363162 hasAuthorship W3024363162A5045072724 @default.
• W3024363162 hasAuthorship W3024363162A5046168760 @default.
• W3024363162 hasBestOaLocation W30243631621 @default.
• W3024363162 hasConcept C120665830 @default.
• W3024363162 hasConcept C121332964 @default.
• W3024363162 hasConcept C121608353 @default.
• W3024363162 hasConcept C126322002 @default.
• W3024363162 hasConcept C126894567 @default.
• W3024363162 hasConcept C141071460 @default.
• W3024363162 hasConcept C143998085 @default.
• W3024363162 hasConcept C2777899217 @default.
• W3024363162 hasConcept C2780192828 @default.
• W3024363162 hasConcept C44249647 @default.
• W3024363162 hasConcept C509974204 @default.
• W3024363162 hasConcept C61511704 @default.
• W3024363162 hasConcept C68443243 @default.
• W3024363162 hasConcept C71924100 @default.
• W3024363162 hasConcept C72563966 @default.
• W3024363162 hasConcept C88879693 @default.
• W3024363162 hasConcept C89560881 @default.
• W3024363162 hasConcept C90924648 @default.
• W3024363162 hasConceptScore W3024363162C120665830 @default.
• W3024363162 hasConceptScore W3024363162C121332964 @default.
• W3024363162 hasConceptScore W3024363162C121608353 @default.
• W3024363162 hasConceptScore W3024363162C126322002 @default.
• W3024363162 hasConceptScore W3024363162C126894567 @default.
• W3024363162 hasConceptScore W3024363162C141071460 @default.
• W3024363162 hasConceptScore W3024363162C143998085 @default.
• W3024363162 hasConceptScore W3024363162C2777899217 @default.
• W3024363162 hasConceptScore W3024363162C2780192828 @default.
• W3024363162 hasConceptScore W3024363162C44249647 @default.
• W3024363162 hasConceptScore W3024363162C509974204 @default.
• W3024363162 hasConceptScore W3024363162C61511704 @default.
• W3024363162 hasConceptScore W3024363162C68443243 @default.
• W3024363162 hasConceptScore W3024363162C71924100 @default.
• W3024363162 hasConceptScore W3024363162C72563966 @default.
• W3024363162 hasConceptScore W3024363162C88879693 @default.
• W3024363162 hasConceptScore W3024363162C89560881 @default.
• W3024363162 hasConceptScore W3024363162C90924648 @default.
• W3024363162 hasIssue "13" @default.
• W3024363162 hasLocation W30243631621 @default.
• W3024363162 hasLocation W30243631622 @default.
• W3024363162 hasLocation W30243631623 @default.
• W3024363162 hasOpenAccess W3024363162 @default.
• W3024363162 hasPrimaryLocation W30243631621 @default.

• next